Cheryl R. Blanchard, Ph.D.

Cheryl R. Blanchard, Ph.D., a leader in US HealthTech, is President and CEO of Anika Therapeutics, a global joint preservation company. With a Ph.D. in Materials Science and Engineering, she leverages deep expertise in biologics, drug delivery, and medical devices. Blanchard previously led Microchips Biotech and held officer positions at Zimmer, Inc., where she founded its Joint Preservation/Regenerative Medicine business. She drives Anika’s focus on early intervention orthopedic care, developing minimally invasive products for osteoarthritis pain management and regenerative solutions.